Сalprotectin in the blood plasma as a new biomarker for assessing the activity of rheumatoid arthritis
Aim. To study the potential use and information value of calprotectin in the blood plasma as a new biomarker for determining the activity of rheumatoid arthritis (RA).Materials and methods. The study included 113 people. The treatment group consisted of 79 patients diagnosed with RA; the average age...
Saved in:
Main Authors: | A. A. Korolkova, V. V. Khizha, D. I. Kozlova, A. L. Maslyanskiy, T. V. Vavilova |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2022-10-01
|
Series: | Бюллетень сибирской медицины |
Subjects: | |
Online Access: | https://bulletin.ssmu.ru/jour/article/view/4907 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamics of the level of calprotectin in patients with rheumatoid arthritis during rituximab biosimilar (Acellbia “Biocad”) therapy
by: A. S. Avdeeva, et al.
Published: (2021-09-01) -
Serum calprotectin levels: A measure of disease activity in rheumatoid arthritis
by: Pranshu Dhingra, et al.
Published: (2025-01-01) -
CLINICAL SIGNIFICANCE OF CALPROTECTIN IN RHEUMATIC DISEASES
by: A. S. Avdeeva
Published: (2018-09-01) -
THE EFFECT OF ABATACEPT ON BLOOD BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-09-01) -
PROVISION OF VITAMINS AND CALCIUM IN RHEUMATOID ARTHRITIS: ESTIMATION OF INTAKE AND PLASMA CONCENTRATIONS
by: V. N. Khodyrev, et al.
Published: (2015-03-01)